8-KThe WireRoutine
Bylaw Amendment
Filed Jun 28, 2021 · 5y ago · Accession 0001564590-21-034792
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Jun 28, 2021
- Report date
- Jun 28, 2021
- Document
- abio-8k_20210628.htm
- Size
- 266 KB